WallStreetAngle

Stock analysis using Citadel risk, Millennium sizing, and Bridgewater setup. 1-10 rating. Price levels for "appealing" and "all in." Not advice.

[WallStreetAngle @WallStreetAngle]

$META Connect 2026 (around mid-week) potential AI/hardware updates.

[Republicans @Republicans]

First President to lower Prescription drug prices 💸

[WallStreetAngle @WallStreetAngle]

Stock highlight $SHIP

Dry bulk shipping (iron ore, coal). Strong Q2 results (EPS beat with major YoY growth), solid utilization, attractive dividend, and positive industry positioning.

A (Strong Buy); recent price around $18.81 with analyst targets up to $25

[WallStreetAngle @WallStreetAngle]

— plus the Beige Book. Meta's Connect event starts.
• Thu: the big day — Costco earnings after the close, jobless claims, new home sales, and a Trump–Xi meeting.
• Fri: durable goods orders + final consumer sentiment.

[WallStreetAngle @WallStreetAngle]

This week's catalysts
• Mon: quiet data day; Fed's Goolsbee speaks midday. Thin Asia with Japan closed.

• Tue: three Fed speakers (Williams, Jefferson, Barkin) in one afternoon + a 2-year Treasury auction.

• Wed: flash PMIs (2:45pm ET) — first real data since the hike

[WallStreetAngle @WallStreetAngle]

$CVX | $208.60

Appealing: $185–195 | Full-size: $165–175 |

Invalidation: close below $155 or dividend cut / buybacks halted with oil still mid-cycle

Horizon: 12–18 months | Next date: Q3 print Oct 23

A cooler oil tape is a headwind for the multiple even if volumes stay high

[WallStreetAngle @WallStreetAngle]

Same cycle as $NVDA , different product (custom + networking + VMware). Count them as one AI-infrastructure risk bucket.

[WallStreetAngle @WallStreetAngle]

$AVGO $365

Add at : $330–350

Full-size: $300–320, cap 4–5% (do not double-count with a max NVDA weight)

Trim: 20% into $450+ if FY27 AI is not raised and the multiple expands anyway

Kill: close below $295, or AI revenue sequentially breaks without a booked-offset

[Luke Bruni Invests @LukeBruni17]

These 4 stocks is CRASHING ‼️

But I believe it’s worth looking 👇🏻

1. Nike $NKE

[WallStreetAngle @WallStreetAngle]

Drop any stock ticker in the replies and I’ll run it through my full analysis.

I’ll break down:
• Current valuation
• Key financials & trends
• Risks and catalysts
• Overall take

No fluff. Just clear, honest analysis.
What’s the first ticker you want me to look at?

[WallStreetAngle @WallStreetAngle]

Market is pricing: a quality compounder at a full multiple — iPhone cycle + services + buybacks, not an AI-re-rating.

Our angle: the business is excellent and capex-light; at ~35x forward you are paying for the franchise, not buying a discount.

[WallStreetAngle @WallStreetAngle]

$AAPL | $319.70 | Rating 6.0 / 10 | Conviction: medium

Appealing: $275–290 | Full-size: $245–265 | Invalidation: close below $240 or Sept-qtr growth + margin both miss with no mix offset

[WallStreetAngle @WallStreetAngle]

history. Not a 10 because of concentration, financing/circularity optics, and the fact that any AI-spend air pocket will hit this stock first.

[WallStreetAngle @WallStreetAngle]

$NVDA $217.55

52-week: $164–$237
Cap: ~$5.25T
Trailing P/E: ~28x
Forward P/E: ~18–24x
Yield: ~0.5% ·
Consensus: Strong Buy · Avg target: ~$320

Rating: 8.0 / 10
Growth, cash generation, and visibility are still exceptional, and the multiple has compressed versus Nvidia’s own

[WallStreetAngle @WallStreetAngle]

Highly liquid for its size, elevated volume on news. Volatility is structural (beta ~2.6). The May–August drawdown from $151 to the $60 already priced a lot of caution; further downside is possible if Neutron slips again.

[WallStreetAngle @WallStreetAngle]

$RKLB Price: $64.39 (Aug 28 close) · 52-week: $37.57–$151 · Cap: ~$39–41B

Rating: 5.5 / 10
Interesting after a large drawdown, but still priced for success that has not yet been demonstrated. Not a buy-now core position.

[WallStreetAngle @WallStreetAngle]

A small speculative starter is only justified if you accept binary hardware risk and can hold through potential further delays.

Appealing (tiny starter)

48–55Deeper discount if the market further questions 2026/early-2027 Neutron timing. Better risk/reward for a small position.

[WallStreetAngle @WallStreetAngle]

Full-size (still small risk budget)

$38–45Closer to the 52-week low zone and more conservative scenarios. Only size up with clear evidence Neutron is on track or with a hard, pre-defined stop.

[WallStreetAngle @WallStreetAngle]

Full-size

$480–500Deeper discount to Street targets and closer to more conservative intrinsic estimates. Requires conviction that the ad engine holds and AI eventually lifts returns.

[WallStreetAngle @WallStreetAngle]

$META Price: $578 · 52-week: $520–$791 · Cap: ~$1.47T

Rating: 7.0 / 10
Better risk/reward than many large-cap growth names after the derating, but not a 9–10 “buy now” while free cash flow is being deliberately crushed. Starter position is reasonable;

[WallStreetAngle @WallStreetAngle]

Appealing (starter / add)

$520–540Near 52-week low zone. Better margin of safety if ad growth stays mid-20s and CapEx guidance doesn’t rise again.